M96.0 Insurance Policy Changes

ICD-10 M96.0 is officially defined as "Pseudarthrosis after fusion or arthrodesis." code M96.0 is referenced in 5 tracked payer policy changes from Excellus BlueCross BlueShield and Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code M96.0 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Excellus BlueCross BlueShield · Effective Jan 1, 2027Medium impact
Spine Procedures for Managed Medicaid (MMC), Health and Recovery Plan (HARP), Child Health Plus (CHP), and Essential Plan (EP) Members - (Effective Date - 2027-01-01) 7.01.126
Excellus BlueCross BlueShield policy 7.01.126 sets medical necessity criteria for spine procedures for Managed Medicaid, Health and Recovery Plan (HARP), Child Health Plus (CHP), and Essential Plan (EP) members, with a current effective date of January 1, 2027. It covers cervical arthrodesis, corpectomy, disc arthroplasty, anterior and posterior cervical decompression, lumbar arthrodesis, lumbar decompression, lumbar discectomy, lumbar osteotomy and pediatric scoliosis surgery, and it considers percutaneous lumbar disc decompression and discectomy investigational. A policy edit dated 10/15/26 removed all site-of-care criteria and smoking-status criteria from lumbar decompression requirements.
Excellus BlueCross BlueShield · Effective Oct 15, 2026High impact
Lumbar Fusion - (Effective Date - 2026-10-15) 7.01.117
Excellus BlueCross BlueShield's Lumbar Fusion policy (07.01.117) is effective October 15, 2026. The June 18, 2026 annual review updated the criteria for documentation of nicotine-free status, and the January 22, 2026 off-cycle review changed the pelvic incidence-lumbar lordosis criterion to greater than 15 degrees. The policy covers lumbar fusion with and without decompression, repeat fusion at the same level, adjacent segment disease, fusion after failed disc arthroplasty, pediatric spinal deformity, and spinal osteotomy.
Aetna · Identified Oct 1, 2026Medium impact
Bone and Tendon Graft Substitutes and Adjuncts (CPB 0411, reviewed 2026-08-18)
Aetna considers INFUSE Bone Graft (bone morphogenetic protein-2) medically necessary for lumbar spinal fusion in skeletally mature persons who meet CPB 0743 criteria, when implanted by an ALIF or lateral (OLIF, DLIF, XLIF or LLIF) approach or with 1 or 2 level TLIF procedures, and for acute open tibial shaft fractures stabilized with intramedullary nail fixation when applied within 14 days after the initial fracture. Cadaveric allograft and demineralized bone matrix are medically necessary for spinal fusions and for filling osteochondral defects, and PMMA or calcium sulfate antibiotic beads are medically necessary with intravenous antibiotics for chronic osteomyelitis. Aetna considers INFUSE for ankle and cervical fusions, platelet-rich plasma, and mesenchymal stem cell therapy for orthopedic applications experimental, investigational or unproven.
Aetna · Identified Aug 17, 2026Medium impact
Spinal Surgery: Laminectomy and Fusion (CPB 0743, reviewed 2026-07-30)
Aetna's Clinical Policy Bulletin 0743 sets medical necessity criteria for cervical, thoracic and lumbar laminectomy, laminoplasty, spinal fusion, vertebral corpectomy, and removal of spinal instrumentation. Most covered indications require advanced imaging (CT or MRI) showing at least moderate central, lateral recess or foraminal stenosis, or nerve root or spinal cord compression, at the level matching the clinical findings, and failure of at least 6 weeks of conservative therapy, or 3 months for certain fusion indications such as scoliosis, kyphosis and sub-axial instability. Computer-assisted surgical navigation is approvable only when fusion implants are placed during surgery, and it is not approvable during routine decompression surgery.
Aetna · Identified Aug 14, 2026Medium impact
Bone and Tendon Graft Substitutes and Adjuncts (CPB 0411, reviewed 2025-07-10)
Aetna considers INFUSE Bone Graft (bone morphogenetic protein-2) medically necessary for lumbar spinal fusion in skeletally mature persons who meet the lumbar spinal fusion criteria in CPB 0743 when it is implanted via an anterior (ALIF) or lateral (OLIF, DLIF, XLIF or LLIF) approach or with 1 or 2 level TLIF procedures, and for acute open tibial shaft fractures stabilized with intramedullary nail fixation when applied within 14 days after the initial fracture. Aetna considers INFUSE experimental, investigational, or unproven for ankle fusions, cervical fusions, 3 or more level TLIF procedures, and posterior or postero-lateral lumbar fusions. Cadaveric allograft and demineralized bone matrix are considered medically necessary for spinal fusions and for filling osteochondral defects, PMMA or calcium sulfate antibiotic beads are considered medically necessary with intravenous antibiotics for chronic osteomyelitis, and bone marrow injections are considered medically necessary for unicameral or simple bone cysts, while bone marrow aspirate and mesenchymal stem cell therapy are experimental for most orthopedic uses.

Watch M96.0

Get one email when a payer policy names M96.0, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code M96.0?

There are 5 tracked policy changes affecting code M96.0, including updates from Excellus BlueCross BlueShield, Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code M96.0?

Payers that have issued tracked updates for code M96.0 include: Excellus BlueCross BlueShield, Aetna.

How do I get notified when code M96.0 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code M96.0. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code M96.0?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Spine Procedures for Managed Medicaid (MMC), Health and Recovery Plan (HARP), Child Health Plus (CHP), and Essential Plan (EP) Members - (Effective Date - 2027-01-01) 7.01.126

Lumbar Fusion - (Effective Date - 2026-10-15) 7.01.117

Bone and Tendon Graft Substitutes and Adjuncts (CPB 0411, reviewed 2026-08-18)

Spinal Surgery: Laminectomy and Fusion (CPB 0743, reviewed 2026-07-30)

Bone and Tendon Graft Substitutes and Adjuncts (CPB 0411, reviewed 2025-07-10)

What insurance policy changes affect code M96.0?

Which payers have updated policy for code M96.0?

How do I get notified when code M96.0 policy changes?

Why do payers change policies for code M96.0?